The effect of spironolactone on five androgen-dependent proteins in the ventral prostate of the rat was investigated by two-dimensional gel electrophoresis. Spironolactone was given to intact male, castrated and androgen-stimulated castrated rats. It has been shown that spironolactone had no influence on the synthesis or accumulation of the androgen\x=req-\ dependent proteins in intact animals. However, spironolactone suppressed the restoration of the major androgen-dependent protein of low molecular weight in castrated rats given testosterone. The mechanism by which spironolactone exerts its anti-androgenic activity was shown to be unrelated to its capacity to inhibit the synthesis or accumulation of the five androgen-dependent proteins studied in this investigation.
INTRODUCTION
Spironolactone, the aldosterone antagonist, has been shown to cause regression of prostatic and seminal vesicle tissue in the rat (Basinger & Gittes, 1974) . Several investigators have reported the anti-androgenic activity of spironolactone in man and rat (Steelman, Brooks, Morgan & Patanelli, 1969; Corvol, Michaud, Menard, Freifeld & Mahoudeau, 1975) . The observation that spironolactone is able to block the effects of exogenous androgen in the rat suggests that interaction of the compound with androgen receptors at the target tissue may occur (Bonne & Raynaud, 1974) . Spironolactone has been shown to inhibit competitively the binding of dihydrotestosterone to the cytosolic androgen receptor of the rat ventral prostate (Corvol et al. 1975 ; Pita, Lippman, Thompson, & Loriaux, 1975) and more recently to human androgen-binding protein in prostate and prepuce from newborn infants (Rifka, Pita, Vigersky, Wilson & Loriaux, 1978) .
Several groups of workers have investigated the androgen-dependent proteins synthesized in the rat ventral prostate (Heyns, Peeters & Mous, 1977; Parker, Scrace & Mainwaring, 1978; Lea, Petrusz & French, 1979) . The synthesis of androgen-dependent proteins is believed to be mediated by the androgen receptor in the prostate. Thus any displacement of androgen from the androgen receptor by a competitor such as spironolactone may be expected to influence the synthesis or accumulation of androgen-dependent proteins. This study has investigated the effect of spironolactone on the synthesis and maintenance of a major group of androgen-dependent proteins in the rat ventral prostate. The data for each sample were obtained from an independent experiment and the average ratio of ß : A for each group of animals is listed. Measurements were made on a Gilford Model 250 Spectrophotometer. Only one gel was run of the stimulated castrated rats for quantitation. Numerous other gels were run but they all appeared the same.
In all cases the quantity of dye bound to the ß protein was also compared with the dye bound in a protein which was not markedly altered by androgens. The protein chosen was the spot labelled A which migrated with the characteristic pi and molecular weight of actin (Garrels & Gibson, 1976) . When the dye bound in A was averaged over four gels obtained from a sample of normal prostate, the average absorbance at 600 nm was found to be 0-3. The average absorbance of dye bound in A from samples from castrated animals was 0-31, the same as the value of average absorbance for A from castrated rats treated only with spironolactone ( Table 1 ). The average absorbance of A from intact rats treated with spironolactone and castrated rats treated with spironolactone and testosterone propionate was 0-33 and 0-35 respectively (Table 1) . The difference from the average of 0-32 for the normal samples was less than the 15% experimental error determined from the four normal samples. The loading of the sample for the castrated animal treated with testosterone was about 25% larger than for the other samples given in fig. 3 ) and after castration with spironolactone treatment (PI. 2, fig. 4 ) the ß protein had regressed relative to A. The absolute amount had decreased by almost 25%. On the other hand, giving spironolactone and testosterone propionate simultaneously to a rat castrated 6 days previously blocked the restoration of the ß : A ratio. The absolute quantity of ß on the gel was slightly above the value as seen in the castrated rats (PI. 3, fig. 5 ). That the ß protein was androgen-dependent is demonstrated in PI. 3, fig. 6 in which testosterone treatment begun 6 days after castration had restored the ß : A ratio and the absolute quantity of ß protein.
The group of spots 1-4 (PI. 1, figs 1,2 and PI. 3, figs 5,6) were acidic, high molecular weight (pi < 5-5 < 50 000) proteins whose synthesis was decreased after castration. In PI. 3, fig. 6 the above numbered spots were also restored in castrated rats given stimulation with testosterone propionate for 6 days. We refer to this group of proteins as the high molecular weight, androgen-dependent (HMAD) proteins. These proteins also reappeared on the stained gel from castrated rats given spironolactone and testosterone propionate; the ß protein levels, however, remained close to the level found in castrated animals ( Table 2 shows the quantification of incorporation of label after incubation for 4 h with radioactive methionine in the spots designated 1,2,3,4, ß and A. The rates of synthesis of the ß and A proteins of the HMAD group were similar for the control animals, control rats treated with spironolactone and castrated rats treated with testosterone. The 10% increase in incorporation of label into the ß protein in spironolactone-treated intact compared with intact animals was not considered to be significant since the amount of label uptake varied over a 15% range from gel to gel with the same sample. The prostates from castrated and spironolactone-treated castrated animals showed large declines in the rates of synthesis of the HMAD and ß proteins but normal levels of incorporation in the A protein. On the other hand, the prostate from castrated rats treated with both spironolactone and testosterone incorporated near normal levels of label into the HMAD group but not into the ß protein. fig. 5 that spironolactone treatment blocked the ability of testosterone to reduce the synthesis of and C to normal levels.
DISCUSSION
The anti-androgenic activity of spironolactone has been studied extensively (Loriaux, Menard, Taylor, Pita & Santen, 1976) and it has been shown that spironolactone interferes with the binding of androgen to the androgen receptor of the rat ventral prostate (Corvol et al. 1975; Pita et al. 1975) . Although the level of spironolactone given to intact animals was sufficient to reduce ventral prostate mass by at least 60% neither a reduction in the rate of synthesis nor the accumulation of the HMAD and ß proteins were detectable (PI. 1, figs 1 and 2, Tables 1 and 2 ). Evidence that spironolactone was capable of exerting an anti-androgenic effect was deduced from the experiment in which spironolactone and testosterone were given simultaneously to rats castrated 6 days previously. It was observed that the full restoration of ß protein was blocked but ß protein was fully restored to the intact level of synthesis and accumulation when no treatment with spironolactone was given.
There are a number of possible explanations for the inability of spironolactone to affect the androgen-dependent proteins as markers of androgen action. The level of exogenous spironolactone may not have been sufficient to inhibit the biological effectiveness of endogenous testosterone even though the dose was sufficient to reduce the mass of prostate and seminal vesicle by 60% over a regimen lasting for 6 days. The dose of spironolactone used in this study was five to ten times in excess of doses used to prove anti-androgenic or anti-mineralocorticoid activity in rats. At higher doses of spironolactone the reduction of testosterone formation in the testis would complicate interpretation of any changes in the protein patterns (Stripp, Menard & Zampaglione, 1973 ).
An alternative explanation for the lack of effect of spironolactone on the androgendependent proteins studied in this investigation is based on a model proposed by Roy (1976 
